Ispire Clarifies: Malaysia Plant Does Not Involve Nicotine or Cannabis Products, All Production for Export Only

Jun.10
Ispire Clarifies: Malaysia Plant Does Not Involve Nicotine or Cannabis Products, All Production for Export Only
Ispire stated that its Malaysia facility complies with local laws and only produces semi-finished vaporizer hardware without nicotine or cannabis. All products are for export and not distributed or sold in the local market.

Key Points:

 

·Ispire Malaysia's subsidiary has announced that its production activities are intended exclusively for export.

·The company's products do not contain nicotine or marijuana ingredients, and are not sold in the Malaysian market. 

·Its technology is only meant for adult use and within compliant regions.

 


 

Ispire Malaysia Sdn Bhd, a subsidiary of Ispire, reiterated on June 9th its strict compliance with all applicable laws and regulations in Malaysia.

 

Ispire Malaysia has confirmed that all production activities at its factory in Johor are solely for export and do not involve manufacturing or distributing any e-liquid or gel products containing nicotine or marijuana in Malaysia.

 

In a statement, Inspire's Co-CEO Michael Wang said:

 

"Ispire Malaysia operates under strict protocols to ensure that 100% of its production is for export. We believe our operations are fully compliant with Malaysian laws, and we are committed to maintaining transparency and cooperation at both federal and state levels."

 

Key clarifications include:

 

·Not distributed locally: All products manufactured in Malaysia are not sold, distributed, or marketed in the local market.

 

·No nicotine or marijuana ingredients: The factory only produces semi-finished vaporizer hardware, and the production process does not involve e-liquids or gel products. 

 

·Not manufacturing medical devices: While the factory is capable of producing certified components, it has not currently produced any medical devices. Any future activities in this field will require comprehensive regulatory review. 

 

·Advanced safety features: Ispire products will integrate age restrictions and geofencing technology based on blockchain, ensuring that only adults and compliant regions can use them. The company's patented technology has been submitted for review by the U.S. Food and Drug Administration (FDA).

 

The company pointed out that recent rumors about cannabis products pertain to its legal product marketing materials in the United States, and do not reflect the nature of its operations in Malaysia.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Chicago CBP Seizes $358,000 Worth of Illegal Vapes
U.S. Chicago CBP Seizes $358,000 Worth of Illegal Vapes
U.S. Customs and Border Protection (CBP) officers in Chicago seized 43,200 illicit vaping products valued at over $358,000 for violating the Federal Food, Drug, and Cosmetic Act. The shipment originated from China and was destined for Mississippi.
Nov.07 by 2FIRSTS.ai
Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders
Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders
Social media users reported purchasing Altria’s new nicotine pouch, on!PLUS, in the United States. 2Firsts found that the official on! website had temporarily opened online purchase and store locator functions. The product has not received FDA authorization. Around the same time, British American Tobacco (BAT) suspended its unlicensed Vuse One vape launch in the U.S. amid regulatory pressure.
Oct.28 by 2FIRSTS.ai
Company | British American Tobacco launches "Vapers Deserve Better" campaign in the UK, calling for mandatory testing and retail licensing
Company | British American Tobacco launches "Vapers Deserve Better" campaign in the UK, calling for mandatory testing and retail licensing
British American Tobacco UK (BAT UK) announced the launch of its "Vapers Deserve Better" campaign this week, emphasizing the need for a responsible regulatory framework to combat non-compliant operators who ignore regulations and quality standards. The campaign advocates for mandatory pre-market testing, a national retail licensing system, and stricter penalties for offenders.
Sep.29 by 2FIRSTS.ai
Congress Calls on FDA to Allocate at Least $200 Million for ENDS Enforcement, Multi-Agency Task Force to Target Illegal e-Cigarette Imports. IKE Tech and Ispire Utilize Blockchain and Age Verification Technology to Support Regulation, Submit Chips as Part
Congress Calls on FDA to Allocate at Least $200 Million for ENDS Enforcement, Multi-Agency Task Force to Target Illegal e-Cigarette Imports. IKE Tech and Ispire Utilize Blockchain and Age Verification Technology to Support Regulation, Submit Chips as Part
Congress demands FDA allocate at least $200 million for ENDS enforcement; multi-agency task force to combat illegal e-cigarette imports.
Nov.18 by 2FIRSTS.ai
California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case
California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case
U.S. District Judge William Orrick of the Northern District of California indicated on Friday that he will likely certify classes of direct and indirect purchasers accusing e-cigarette makers Juul Labs Inc. and former rival Altria Group Inc. of conspiring to limit product variety and violate antitrust laws.
Oct.20 by 2FIRSTS.ai
2Firsts Observation|ZYN Launches Brand Advertisement at Dubai International Airport, Promoting Itself as “World’s No.1 Nicotine Pouch Brand”
2Firsts Observation|ZYN Launches Brand Advertisement at Dubai International Airport, Promoting Itself as “World’s No.1 Nicotine Pouch Brand”
2Firsts observed that Philip Morris International’s (PMI) nicotine pouch brand ZYN has launched digital screen advertisements and product displays at the Dubai International Airport Duty Free area, featuring flavors such as Spearmint, Black Cherry, and Cool Mint, while promoting itself with the slogan “World’s No.1 Nicotine Pouch Brand.”
Nov.13 by 2FIRSTS.ai